泰格医药
(300347)
| 流通市值：287.17亿 | | | 总市值：438.26亿 |
| 流通股本：5.60亿 | | | 总股本：8.55亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 5,791,528,067.34 | 3,707,560,174.2 | 1,801,473,935.03 | 6,832,800,615.35 |
| 营业总成本 | 5,216,682,770.59 | 3,348,891,613.17 | 1,644,573,250.45 | 6,312,645,254.48 |
| 其他经营收益 | | | | |
| 营业利润 | 12,187,083.41 | -78,648,748.89 | 405,838,528.23 | 1,009,419,969 |
| 利润总额 | 9,900,471.93 | -80,215,307.94 | 405,944,308.45 | 1,003,215,119.99 |
| 净利润 | -124,052,657.36 | -185,471,319.77 | 330,083,645.62 | 805,056,174.52 |
| 每股收益 | | | | |
| 其他综合收益 | -172,607,574.25 | -176,529,004.82 | -87,366,018.26 | -53,653,137.05 |
| 综合收益总额 | -296,660,231.61 | -362,000,324.59 | 242,717,627.36 | 751,403,037.47 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 6,836,624,618.1 | 6,608,333,962.98 | 6,629,249,323.65 | 6,177,196,741.89 |
| 非流动资产: | | | | |
| 非流动资产合计 | 21,149,190,418.86 | 21,284,860,526.57 | 22,171,235,477.15 | 22,181,598,416.28 |
| 资产总计 | 27,985,815,036.96 | 27,893,194,489.55 | 28,800,484,800.8 | 28,358,795,158.17 |
| 流动负债: | | | | |
| 流动负债合计 | 2,688,347,982.97 | 2,658,743,846.48 | 2,879,679,287.51 | 2,835,474,052.17 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,036,171,224.09 | 2,142,884,678 | 1,355,885,340.22 | 1,266,895,915.05 |
| 负债合计 | 4,724,519,207.06 | 4,801,628,524.48 | 4,235,564,627.73 | 4,102,369,967.22 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 19,637,700,367.95 | 19,477,217,580.62 | 20,916,402,606.45 | 20,959,506,514.77 |
| 股东权益合计 | 23,261,295,829.9 | 23,091,565,965.07 | 24,564,920,173.07 | 24,256,425,190.95 |
| 负债和股东权益合计 | 27,985,815,036.96 | 27,893,194,489.55 | 28,800,484,800.8 | 28,358,795,158.17 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 6,434,895,976.63 | 4,182,554,947.92 | 2,090,446,149.88 | 7,371,765,963.04 |
| 经营活动现金流出小计 | 5,663,584,053.18 | 3,756,772,612.63 | 1,772,742,373.52 | 6,253,681,192.5 |
| 经营活动产生的现金流量净额 | 771,311,923.45 | 425,782,335.29 | 317,703,776.36 | 1,118,084,770.54 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,791,294,355.44 | 1,110,906,718.43 | 472,514,032.77 | 2,903,502,466.77 |
| 投资活动现金流出小计 | 1,876,144,015.76 | 1,062,094,433.42 | 418,277,776.93 | 2,411,945,914.54 |
| 投资活动产生的现金流量净额 | -84,849,660.32 | 48,812,285.01 | 54,236,255.84 | 491,556,552.23 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,453,109,495.45 | 1,339,034,826.47 | 348,864,549.16 | 1,422,094,305.84 |
| 筹资活动现金流出小计 | 1,791,528,042.18 | 1,469,614,084.88 | 341,289,381.07 | 3,348,779,515.36 |
| 筹资活动产生的现金流量净额 | -338,418,546.73 | -130,579,258.41 | 7,575,168.09 | -1,926,685,209.52 |
| 汇率变动对现金及现金等价物的影响 | -30,244,682.58 | -23,544,743.26 | -14,454,893.77 | -8,841,588.41 |
| 现金及现金等价物净增加额 | 317,799,033.82 | 320,470,618.63 | 365,060,306.52 | -325,885,475.16 |
| 期末现金及现金等价物余额 | 2,040,407,411.5 | 2,043,078,996.31 | 2,087,668,684.2 | 1,722,608,377.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 320,470,618.63 | - | -325,885,475.16 |
最新报告期：2026-11-10| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,王宏雨 | 0.00 | 1.52 | 1.90 | 2026-11-10 |
| 东吴证券 | 朱国广 | 0.03 | 1.52 | 1.93 | 2026-11-03 |
| 平安证券 | 叶寅,倪亦道,王钰畅 | 0.65 | 1.32 | 1.97 | 2026-09-20 |
| 浙商证券 | 郭双喜 | 0.40 | 1.48 | 1.93 | 2026-08-31 |
| 招商证券 | 梁广楷,许菲菲 | 0.82 | 1.83 | 2.66 | 2026-08-30 |